 In this national multicenter prospective open label trial, patients will be randomized 1:1 to experimental group CMS group : Conus Medullaris Stimulation using pentapolar surgical lead, plus optimal medical management or to control group OMM group : optimal medical management alone and followed for 12 months, in intention to treat. 